WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krovetz, H. S.
Right arrow Articles by Horne, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krovetz, H. S.
Right arrow Articles by Horne, W. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 15, 2000, 20(20):7564-7570

C-Terminal Alternative Splicing Changes the Gating Properties of a Human Spinal Cord Calcium Channel alpha 1A Subunit

Howard S. Krovetz, Thomas D. Helton, Anne L. Crews, and William A. Horne

Department of Anatomy, Physiological Sciences, and Radiology, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina 27606


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The calcium channel alpha 1A subunit gene codes for proteins with diverse structure and function. This diversity may be important for fine tuning neurotransmitter release at central and peripheral synapses. The alpha 1A C terminus, which serves a critical role in processing information from intracellular signaling molecules, is capable of undergoing extensive alternative splicing. The purpose of this study was to determine the extent to which C-terminal alternative splicing affects some of the fundamental biophysical properties of alpha 1A subunits. Specifically, the biophysical properties of two alternatively spliced alpha 1A subunits were compared. One variant was identical to an isoform identified previously in human brain, and the other was a novel isoform isolated from human spinal cord. The variants differed by two amino acids (NP) in the extracellular linker between transmembrane segments IVS3 and IVS4 and in two C-terminal regions encoded by exons 37 and 44. Expression in Xenopus oocytes demonstrated that the two variants were similar with respect to current-voltage relationships and the voltage dependence of steady-state activation and inactivation. However, the rates of activation, inactivation, deactivation, and recovery from inactivation were all significantly slower for the spinal cord variant. A chimeric strategy demonstrated that the inclusion of the sequence encoded by exon 44 specifically affects the rate of inactivation. These findings demonstrate that C-terminal structural changes alone can influence the way in which alpha 1A subunits respond to a depolarizing stimulus and add to the developing picture of the C terminus as a critical domain in the regulation of Ca2+ channel function.

Key words: spinal cord; cerebellum; calcium channel; alpha 1A subunit; voltage clamp; alternative splicing; C terminus


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Multiple types of high-voltage-activated Ca2+ channels (L, N, P, Q, and R) coordinate a variety of Ca2+-dependent processes, including gene expression, signal propagation, and neurotransmitter release (Tsien et al., 1991; Zhang et al., 1993; Dunlap et al., 1995). These channels can be distinguished by their biophysical and pharmacological properties. L- and R-type channels, found on cell bodies and proximal dendrites, regulate gene transcription and signal propagation (Westenbroek et al., 1990; Murphy et al., 1991; Yokoyama et al., 1995), whereas synaptic N-, P-, and Q-type channels regulate neurotransmitter release (Turner et al., 1992; Takahashi and Momiyama, 1993; Wheeler et al., 1994). The Ca2+ channel complex consists of four subunits, alpha 1, alpha 2/delta , beta , and gamma . With the exception of P- and Q-type channels, the different neuronal Ca2+ channel phenotypes arise primarily from the expression of five unique alpha 1 subunit genes (Tsien et al., 1991; Jun et al., 1999). These genes (A-E) are differentially distributed throughout brain and spinal cord (Murphy et al., 1991; Takahashi and Momiyama, 1993; Westenbroek et al., 1998) and encode large proteins consisting of four homologous domains (I-IV) containing six transmembrane segments each (S1-S6) (Tsien et al., 1991; Zhang et al., 1993).

Alternative splicing of the alpha 1A gene results in the expression of multiple Ca2+ channel phenotypes (Sutton et al., 1998; Bourinet et al., 1999; Hans et al., 1999; Jun et al., 1999). Splicing of two amino acids (NP) in the alpha 1A IVS3-IVS4 linker affects rates of activation and inactivation, the voltage dependence of inactivation, and the affinity of alpha 1A for omega -Aga IVA (Sutton et al., 1998; Bourinet et al., 1999; Hans et al., 1999; Lin et al., 1999). The biophysical and pharmacological properties of alpha 1A Ca2+ channels are also influenced by intracellular signaling molecules. Coexpression of alpha 1A with different beta  subunit subtypes alters inactivation rates and omega -Aga IVA affinity (Moreno et al., 1997). Generally, alpha 1A subunit function is inhibited by interactions with G-proteins or syntaxin-1A (Zhang et al., 1996; Qin et al., 1997; Sutton et al., 1999) and enhanced by protein kinase C (Zamponi et al., 1997; Bourinet et al., 1999). Calcium-activated calmodulin has dual effects on alpha 1A subunit function (Lee et al., 1999).

Determination of genomic exon-intron boundaries (Ophoff et al., 1996) and isolation of several alpha 1A C-terminal splice variants (Zhuchenko et al., 1997) suggest that there are four exons between IVS3-IVS4 and the C-terminal stop codon that undergo alternative splicing. This implies that 16 combinations of these four exons are possible. Eight combinations have been isolated previously from human brain (Ophoff et al., 1996; Zhuchenko et al., 1997; Hans et al., 1999). In this study, a ninth is isolated from human spinal cord. Biophysical characterization of this alpha 1A variant reveals that its rates of activation, inactivation, deactivation, and recovery from inactivation are all significantly slower than that of an alpha 1A variant from cerebellum. The rate of inactivation was especially affected by sequence encoded by a single exon. These findings suggest that variation in alpha 1A C-terminal structure provides an added mechanism for functional diversity among neuronal Ca2+ channel subtypes.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Human spinal cord library screening. Calcium channel subunit cDNAs were isolated from an oligo-dT and random-primed human spinal cord lambda gt11 5' stretch cDNA library (Clontech, Palo Alto, CA) by the use of a nonradioactive digoxigenin-labeling and colorimetric detection system (Roche Molecular Biochemicals, Indianapolis, IN). The library was constructed from mRNA isolated from whole spinal cords pooled from 26 male or female Caucasians, ages 16-75, who died of sudden death syndrome. The insert size range of the library was 0.8-7.0 kb (average size of 1.7 kb). Plaque-purified phage DNAs were isolated using a Lambda Prep Kit (Qiagen, Santa Clara, CA) and digested with the restriction endonuclease EcoRI (Roche Molecular Biochemicals, supplier of all endonucleases used). Southern blot analysis was used to assess insert size. cDNA isolates were ligated into pBluescriptII (Stratagene, La Jolla, CA) for sequencing. The inserts were subjected to exonuclease III/SI nuclease digestion (Erase-A-Base; Promega, Madison, WI) before sequencing. PCR-based cycle sequencing (FS chemistry; PE Biosystems, Foster City, CA) with universal primers and custom internal primers (Genosys, The Woodlands, TX) was used for each clone. Sequence was obtained using an ABI Prism 310 Genetic DNA analyzer, and data were analyzed using ABI Prism DNA Sequencing Software (version 2.12; PE Biosystems). Sequence comparisons, alignments, and restriction maps were performed using Lasergene Software (DNAStar, Madison, WI). 5' RACE (Roche Molecular Biochemicals) was used with human spinal cord poly(A+) RNA (Clontech) to create a 5' probe for the alpha 1A screening. This RNA came from a pool of 92 male or female Caucasians, ages 16-75, who died from sudden death syndrome.

The library-screening process was initiated with a cDNA probe (alpha 1-EST) obtained from the NCBI dbEST database (1.8 kb human fetal brain alpha 1A fragment; GenBank number H14053). Clone alpha 1-9, extending from nucleotide 3416 to the 3'-untranslated region, was the longest of 24 3' cDNAs isolated in the first rounds of screening. Five alpha 1 cDNAs were isolated in a second round, in which a 1 kb 5' EcoRI fragment of clone alpha 1-9 was used as the probe. The longest clone isolated in this round, extending from nucleotides 2399 to 4551, was subsequently labeled and used as a probe to identify alpha 1-38 (which contained an EcoRI/EcoRI fragment from 1800 to 4551). To isolate the 5' portion of the alpha 1A sequence, a probe containing nucleotides 946 to 1800 was created by reverse transcription-PCR with human spinal cord RNA. Library screening with this probe yielded 14 cDNAs, one of which, clone alpha 1-80, extended from the 5'-untranslated region to a region beyond the EcoRI site at nucleotide 1800.

Clone construction and sequencing. Full-length spinal cord alpha 1A cDNAs were assembled in several steps. Initially, PCR was performed using PFU Polymerase (Stratagene) and custom primers (Genosys) to truncate the 5'-untranslated region of alpha 1-80 and to insert an idealized Kozak (Kozak, 1991) sequence into the shortened 5' end of the construct. The resulting 1.1 kb fragment was then ligated into the pT-Adv vector (Clontech) and sequenced to ensure that there were no polymerase errors. This PCR product was cut with the restriction endonuclease NotI, and the resulting fragment was ligated into EcoRV/NotI-prepared pBluescriptII. The untruncated alpha 1-80 was cut with NotI, and the resulting 900 bp fragment was then ligated into the shortened 5' clone by the use of NotI. The resulting clone (referred to as 5'short) spans from the shortened 5'-untranslated sequence to the EcoRI site at nucleotide1800.

In the next step, a 3' cDNA extending from nucleotide 3826 to the 3'-untranslated region of the clone, alpha 1-10, was cut with NotI to eliminate the EcoRI site located in the polylinker of pBluescriptII. The construct was then cut with SacI, blunted using the Klenow fragment (Roche Molecular Biochemicals), and cut with EcoRI to yield a 3.5 kb fragment spanning from the EcoRI site at 4551 to the 3'-untranslated region. This fragment was ligated into EcoRI/SmaI-prepared pBluescriptII, removed with EcoRI/BamHI, and ligated into the EcoRI/BamHI-cut vector containing 5'short. Thus, the resulting construct (5'short + 3') extended from the shortened 5'-untranslated region to the EcoRI site at 1800 and continued from the EcoRI site at 4551 to the 3'-untranslated region. In the final step, an EcoRI fragment of alpha 1-38 extending from 1801 to 4550 was cloned into EcoRI-cut 5'short + 3'. The fully constructed clone alpha 1A-C1 was then sequenced to ensure the fidelity of the construction process. Exchanging the C-terminal domain of alpha 1A-C1 with that of alpha 1-EST and alpha 1-9 created alpha 1A-C2 and alpha 1A-C16, respectively. Thus, both alpha 1A-C2 and alpha 1A-C16 are constructed of the same cDNAs up to nucleotide 4550 but then contain segments of different cDNAs beyond this point.

The rabbit Chbeta 1a and alpha 2a/delta clones used in this study were provided by T. Tanabe (Tokyo Medical and Dental University, Tokyo, Japan). The Chbeta 1b, Chbeta 3, and Chbeta 4 subunits were cloned from the same human spinal cord library described above and are nearly identical to previously reported sequences (Chbeta 1b, GenBank number M923303; Chbeta 3, GenBank number U07139; and Chbeta 4, GenBank number U95020).

Electrophysiology and data analysis. Standard Xenopus laevis oocyte expression methods were used to characterize the alpha 1A splice variants. Briefly, full-length alpha 1A subunit cDNA was in vitro transcribed (Ambion, Austin, TX). The resulting cRNA was injected into defolliculated X. laevis oocytes (stage V-VI) along with equimolar ratios of rabbit alpha 2a/delta and Chbeta cRNAs (0.40 µg/ml alpha 1A; 0.16 µg/ml alpha 2a/delta ; 0.08 µg/ml Chbeta in a total of 46 nl). Ca2+ channel currents were recorded by standard two-microelectrode voltage-clamp techniques using a Warner amplifier (OC-725B) at room temperature (20-22°C), and data were collected using pCLAMP6 software (Axon Instruments, Foster City, CA). The bath solution contained the following: 40 mM Ba(OH)2, 40 mM TEA-OH, 2 mM KOH, and 5 mM HEPES, with pH adjusted to 7.4 with methanesulphonic acid. Microelectrodes were filled with 3 M KCl, and the resistances of the current and voltage electrodes were 0.3-1.5 MOmega . Data were filtered at 2 kHz and sampled at 10 kHz. Currents were recorded 6-18 d after injection. The holding potential of all experiments was -100 mV unless otherwise noted. Control oocytes (alpha 1A alone or uninjected oocytes) did not yield currents >50 nA. Because of lower expression levels when Chbeta subunits other than the rabbit Chbeta 1a were used, currents as low as 150 nA were included in the initial portion of the study. Only currents >0.5 µA were analyzed for the remainder of this work. To diminish the contamination caused by the Ca2+-activated Cl- channels, currents that exhibited slow deactivation (tau  > 10 msec) were excluded from analysis. The leak current and capacitive current transients were subtracted on-line by a standard P/4 protocol. Data were analyzed using pCLAMP6 and Excel 7.0 (Microsoft, Redmond, WA). For statistical analysis, a one-way ANOVA test was used followed by a Fisher's PLSD test using Statview software (SAS Institute, Cary, NC).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Two alpha 1A C-terminal splice variants, alpha 1A-C2 and alpha 1A-C16, are the focus of this study (Fig. 1A). These variants were assembled from a parent spinal cord construct, alpha 1A-C1, and thus are identical up to homology domain IV. Sequencing of the alpha 1A-C1 cDNA through domain IV revealed only three differences when compared with an alpha 1A cDNA isolated from human cerebellum (GenBank number AF004883). A deletion (Delta G419) identified previously in rat brain was found in the region encoding the intracellular linker between homology domains I and II (Bourinet et al., 1999). A mutation resulting in a charge change (M537R) was found in the region encoding transmembrane segment IIS2. A nine nucleotide deletion resulting in the loss of amino acids 726-728 (VEA) was found in the region encoding the intracellular linker between homology domains II and III. This deletion has been identified in another alpha 1A variant from human brain (GenBank number U79666). The spinal cord alpha 1A-C1 cDNA did not contain a six nucleotide insertion that codes for the amino acid sequence NP in the extracellular linker between IVS3 and IVS4.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1.   Alternative splicing of alpha 1A domain IV and C-terminal exons. A, Alternatively spliced exon patterns of alpha 1A-C2 (middle bar) and alpha 1A-C16 (bottom bar) cDNAs relative to a consensus protein that is a composite of known exons (top bar). This figure is drawn on the basis of our data and that of others (Ophoff et al., 1996; Zhuchenko et al., 1997; Hans et al., 1999). Note that the NP sequence is located in the extracellular loop between transmembrane domains IVS3 and IVS4. B, The amino acid sequences of exons 37a, 37b, and 44. Regions of variation are highlighted in black. Charged amino acids are denoted by an asterisk.

The alpha 1-EST and alpha 1-9 C-terminal cDNAs used to construct alpha 1A-C2 and alpha 1A-C16, respectively, differed from the C terminus of alpha 1A-C1 and other alpha 1A clones in sequences that could be traced to specific exon-intron boundaries (Ophoff et al., 1996). The alpha 1-EST cDNA did not extend to domain IV, and therefore alpha 1A-C2, like alpha 1A-C1, lacks NP (Fig. 1A). The alpha 1-9 cDNA contained the NP exon, and this region is therefore present in alpha 1A-C16. The alpha 1-EST cDNA contained one version of exon 37 (37a), whereas alpha 1-9 contained a second (37b). There are nine amino acid changes in this region including one charge change (Fig. 1B, L1851K). The alpha 1-EST cDNA contained 12 amino acids encoded by exon 44, whereas alpha 1-9 did not. Interestingly, five of these amino acids are positively charged (Fig. 1B). A 3' GGCAG insert in exon 46 that would extend the open reading frame to exon 47, although present in alpha 1A-C1 (data not shown), was not found in either alpha 1-EST or alpha 1-9 (Fig. 1A). Thus, neither alpha 1A-C2 nor alpha 1A-C16 contains the ~240 amino acid domain encoded by exon 47. The end result is that alpha 1A-C2 is identical to the human cerebellar clone described above, and alpha 1A-C16 represents a novel spinal cord clone containing a unique arrangement of NP and C-terminal exons.

To determine the functional consequences of C-terminal splicing, both alpha 1A-C2 and alpha 1A-C16 were coexpressed with rabbit alpha 2a/delta and a rabbit Chbeta 1a or a human Chbeta 1b, Chbeta 3, or Chbeta 4 subunit in Xenopus oocytes. Representative current traces demonstrate that alpha 1A-C2 inactivates more rapidly than does alpha 1A-C16 when associated with Chbeta 1a, Chbeta 1b, or Chbeta 3 subunits (Fig. 2A-C; see below). When coexpressed with the Chbeta 4 subunit, the alpha 1A-C2 complex appears to inactivate at approximately the same rate as alpha 1A-C16 (Fig. 2D) although the low expression levels of this complex make interpretation difficult. As seen in Figure 2A, the deactivation rate of the alpha 1A-C2 variant was slightly faster than that of alpha 1A-C16 [tau deactivation (alpha 1A-C2) = 5.6 ± 0.3 msec at -80 mV (n = 7); tau deactivation (alpha 1A-C16) = 6.6 ± 0.3 msec at -80 mV (n = 6)]. When expressed with each of the Chbeta subunits, the current-voltage relationships of alpha 1A-C2 and alpha 1A-C16 were essentially indistinguishable (Fig. 2). With all Chbeta subunits, both alpha 1A variants had peak inward currents at +15 to +20 mV. Additionally, the voltages at which 1% of the maximal current was obtained were nearly identical (Chbeta 1a/alpha 1A-C2 = -19.2 ± 4.4 mV, whereas Chbeta 1a/alpha 1A-C16 = -19.5 ± 5.0 mV; this measurement was not obtained with the other Chbeta subunits because of poor expression levels). Coexpression of the rabbit Chbeta 1a subunit yielded currents two to five times higher than that with any of the human Chbeta subunits (Fig. 2). The goal of this study was to determine the effect of C-terminal alpha 1A splicing on the function of the channel, independent of Chbeta binding to the region. Therefore, the remainder of the study was performed with the Chbeta 1a subunit because it does not appear to bind to this region of the alpha 1A subunit and has the most robust expression levels (Walker et al., 1998).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 2.   Biophysical properties of the alpha 1A-C2 and alpha 1A-C16 subunits coexpressed with rabbit alpha 2a/delta and Chbeta 1a, Chbeta 1b, Chbeta 3, or Chbeta 4 subunits. A-D, Representative current traces of alpha 1A-C2 (top) and alpha 1A-C16 (middle) between -40 and +40 mV with the Chbeta 1a (A), Chbeta 1b (B), Chbeta 3 (C), or Chbeta 4 (D) subunit. Normalized current-voltage relationships (bottom) of alpha 1A-C2 (open diamonds) and alpha 1A-C16 (filled diamonds) with the Chbeta 1a (n = 14 and 20, respectively), Chbeta 1b (n = 21 and 14, respectively), Chbeta 3 (n = 10 and 10, respectively), or Chbeta 4 (n = 26 and 22, respectively) subunit.

The voltage dependency of activation, as determined from tail current measurements, was similar between alpha 1A-C2 and alpha 1A-C16 [Fig. 3A, V1/2 (alpha 1A-C2) = 9.5 ± 1.4 mV; V1/2 (alpha 1A-C16) = 7.3 ± 1.1 mV], as was the voltage dependency of steady-state inactivation (Fig. 3B, V1/2 (alpha 1A-C2) = -37.9 ± 1.4 mV; V1/2 (alpha 1A-C16) = -34.3 ± 1.5 mV]. The time constants of activation and inactivation were described with a single exponential (Fig. 3C,D). The time constants of activation of the alpha 1A-C16 variant, however, were much slower than that of alpha 1A-C2 and varied with membrane potential (Fig. 3E). The tau  values of activation of alpha 1A-C16 ranged from 6.15 ± 0.40 msec at 0 mV to 1.24 ± 0.06 msec at +30 mV, whereas those of alpha 1A-C2 ranged from 2.07 ± 0.51 msec at 0 mV to 0.75 ± 0.12 msec at +30 mV. The time constants of inactivation of the alpha 1A-C16 variant were also slower than that of alpha 1A-C2 (Fig. 3F). The tau  values of inactivation of alpha 1A-C2 ranged from 347 ± 69 msec at -10 mV to 175 ± 11 msec at +50 mV, whereas those of alpha 1A-C16 ranged from 984 ± 325 msec at -10 mV to 338 ± 46 msec at +50 mV. Analysis of the correlation between peak current and the tau  of inactivation demonstrates that slow activation of the ClCa current did not contaminate the apparent rates of inactivation (r = 0.304).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 3.   Voltage dependencies and rates of inactivation and activation of alpha 1A-C2 and alpha 1A-C16 subunit complexes. A, Voltage dependence of activation of alpha 1A-C2 and alpha 1A-C16 as measured from tail current measurements. Inset, Tail currents that were measured after the capacitive current (dashed vertical line) at 0 mV after a 20 msec depolarization to the test potential (-40 to +75 mV in 5 mV increments). Tail currents were normalized to the largest tail current in each series of test pulses. These data were fit with a Boltzmann equation: % I = 1/[1 + exp(-(Vtest - V1/2)/k)]. B, Isochronal inactivation of alpha 1A-C2 and alpha 1A-C16. A 20 sec conditioning pulse ranged from -100 to +40 mV in 10 mV increments. The conditioning pulse was followed by a test pulse to +20 mV for 300 msec. Data were fit with a Boltzmann equation: % I = 1/[1 + exp((Vtest - V1/2)/k)]. C, Single-exponential fits of activation of alpha 1A-C2 and alpha 1A-C16 at +20 mV. Fits are shown as solid black lines. D, Single-exponential fits of inactivation of alpha 1A-C2 and alpha 1A-C16 at +20 mV. Fits are shown as solid black lines. E, Average tau activation of alpha 1A-C2 and alpha 1A-C16 between the voltages 0 and +30 mV. Traces were fit with a single exponential from the onset of the inward current to the time of peak current. For this and all following figures, the asterisks denote statistical significance (p < 0.01) by the use of an ANOVA test. F, Average tau inactivation between -10 and +50 mV for alpha 1A-C2 and alpha 1A-C16. Each point represents a minimum of six recordings. The SEM for each point is shown unless the values were smaller than the symbol. Traces were fit with a single exponential from the peak inward current to the end of the depolarization.

Because alpha 1A subunits are expressed primarily at synapses and high-frequency trains of action potentials govern neurotransmitter release, recovery from inactivation was characterized as a means of predicting how alpha 1A-C2 versus alpha 1A-C16 might respond to repetitive stimulation. Interestingly, at -40 and -60 mV, the rates of recovery from inactivation of alpha 1A-C2 and alpha 1A-C16 are not significantly different (Fig. 4A,D). However, at more negative potentials, the alpha 1A-C2 subunit recovers from inactivation more rapidly than does the alpha 1A-C16 subunit (Fig. 4B-D). A comparison of the fits of these recovery rates with a single-exponential function reveals that the differences in recovery rates become more apparent at increasingly negative potentials (Fig. 4D), showing that the rate of recovery from inactivation of the alpha 1A-C2 subunit is more voltage dependent than that of alpha 1A-C16. Although this difference is greater at potentials not likely to be seen physiologically (-100 to -120 mV), the recovery rate is still significantly different between -70 and -90 mV: at -70 mV, tau recovery alpha 1A-C2 = 398 ± 19 msec, and tau recovery alpha 1A-C16 = 469 ± 23 msec; at -80 mV, tau recovery alpha 1A-C2 = 234 ± 11 msec, and tau recovery alpha 1A-C16 = 321 ± 19 msec; and at -90 mV, tau recovery alpha 1A-C2 = 178 ± 6 msec, and tau recovery alpha 1A-C16 = 251 ± 15 msec. The voltage dependence of the recovery from inactivation is shifted by ~10 mV in the physiological range (Fig. 4D).



View larger version (48K):
[in this window]
[in a new window]
 
Figure 4.   Voltage dependency of recovery from inactivation of the alpha 1A-C2 and alpha 1A-C16 subunit complexes. A-C, Average recoveries of alpha 1A-C2 and alpha 1A-C16 at -60 mV (A), -80 mV (B), and -100 mV (C). A two-pulse protocol was used with an initial test pulse of 600 msec to +30 mV followed by a conditioning pulse (ranging from -40 to -120 mV) of intervals ranging from 20 to 1100 msec. This was followed by a second 200 msec test pulse to +30 mV, I2. The percentage recovery was measured as % Recovery = (I2 - Iend of pulse I1)/(I1 - Iend of pulse I1). Each point shown is the average of six to nine different recordings. The SEM for each point is shown unless the values were smaller than the symbol. The solid lines are the single-exponential fits of the % Recovery. D, Voltage dependency of the rate of recovery from inactivation of alpha 1A-C2 and alpha 1A-C16. tau recovery is the average value derived from single-exponential fits of individual experiments. The asterisks (p < 0.01) and cross (p < 0.05) denote statistical significance by the use of an ANOVA test.

Because the most obvious structural difference between alpha 1A-C2 and alpha 1A-C16 is the presence of the highly charged 12 amino acid segment encoded by exon 44 (Fig. 1A), a chimera was constructed to characterize the influence of this segment on channel gating. The chimera alpha 1A-C14 is identical to alpha 1A-C16 except that it contains the 12 amino acids encoded by exon 44. As expected, the voltage dependencies of activation and steady-state inactivation of alpha 1A-C14 were similar to those of alpha 1A-C16 [V1/2activation (alpha 1A-C14) = 6.7 ± 1.3 mV; V1/2inactivation (alpha 1A-C14) = -33.0 ± 1.1 mV]. The differences between the rates of activation (Fig. 5C) and deactivation [at -80 mV, tau deactivation (alpha 1A-C14) = 6.3 ± 0.4 msec] and the rates of recovery from inactivation (at -100 mV, tau recovery = 216 ± 19 msec; at -80 mV, tau recovery = 316 ± 31 msec; at -60 mV, tau recovery = 520 ± 63 msec) were not statistically significant. The most striking difference between the two variants was the enhancement of the rate of inactivation of alpha 1A-C14 relative to that of alpha 1A-C16 (Fig. 5A,B,D). Moreover, these rates were similar to those of alpha 1A-C2, ranging from 198 ± 14 msec at 0 mV to 133 ± 16 msec at +50 mV.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 5.   Exon 44 enhances the rate of inactivation. A, Current traces of alpha 1A-C14, a clone that contains the 12 amino acids encoded by exon 44, between -50 and +40 mV. B, Current traces of alpha 1A-C16, a clone that does not contain exon 44, between -50 and +40 mV. C, Average tau activation of alpha 1A-C14 and alpha 1A-C16 between 0 and +30 mV. D, Average tau inactivation between 0 and +50 mV for alpha 1A-C14 and alpha 1A-C16. Each point represents a minimum of five recordings. The SEM for each point is shown unless the values were smaller than the symbol. Traces were fit with a single exponential from the peak inward current to the end of the depolarization.

To determine whether the effects of the amino acid segment encoded by exon 44 on the rate of inactivation were background dependent, this exon was removed from alpha 1A-C2 to create alpha 1A-C4. Thus, alpha 1A-C4 is identical to alpha 1A-C2 except that it lacks the 12 amino acids encoded by exon 44. The effect of the removal of exon 44 was indeed to slow the rate of inactivation (Fig. 6A,B,D) without significantly affecting the voltage dependency of activation [V1/2 (alpha 1A-C4) = 7.7 ± 1.0 mV] or inactivation [V1/2 (alpha 1A-C4) = -31.4 ± 1.2 mV]. Interestingly, this construct had a slower rate of activation (Fig. 6A-C).



View larger version (40K):
[in this window]
[in a new window]
 
Figure 6.   In a different C-terminal combination, the exon 44 slows the rate of activation but still enhances the rate of inactivation. A, Current traces of alpha 1A-C2, a clone that contains the 12 amino acids encoded by exon 44, between -50 and +40 mV. B, Current traces of alpha 1A-C4, a clone that does not contain exon 44, between -50 and +40 mV. C, Average tau activation of alpha 1A-C2 and alpha 1A-C4 between 0 and +30 mV. D, Average tau inactivation between 0 and +50 mV for alpha 1A-C2 and alpha 1A-C4. Each point represents a minimum of five recordings. The SEM for each point is shown unless the values were smaller than the symbol. Traces were fit with a single exponential from the peak inward current to the end of the depolarization.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The gating properties of neuronal Ca2+ channels are determined by multiple structural domains within the alpha 1 subunit (Tsien et al., 1991; Catterall, 1995). Our results indicate that C-terminus alternative splicing can influence some of these properties. The C terminus of the alpha 1A subunit is encoded by 12 exons, numbered 36-47 (Ophoff et al., 1996), of which 4 exons, 37, 44, 46, and 47, undergo alternative splicing (Zhuchenko et al., 1997). Depending on the pattern of splicing, the C terminus may vary from 436 to 517 amino acids. Binding sites for several intracellular signaling molecules, which affect channel gating, have been identified within this sequence. An EF-hand Ca2+-binding motif can be aligned to sequence encoded by exons 36 and 37 (de Leon et al., 1995). Calmodulin has been shown to bind to a region of the C terminus encoded by exon 40 (Peterson et al., 1999) and to a calmodulin-binding domain (CBD) identified in the region encoded by exon 42 (Lee et al., 1999). Calcium-dependent binding of calmodulin to the CBD motif speeds inactivation and recovery from inactivation and produces a long-lasting facilitation of Ca2+ current (Lee et al., 1999). Calcium channel beta 4 subunit binding to a region encoded by exons 43-47 has been shown to enhance the rate of inactivation (Walker et al., 1998). In addition, the C terminus appears to be essential for modulation by Gbeta gamma -proteins (Zhang et al., 1996), particularly those regions encoded by exons 45 and 46 (Qin et al., 1997). G-proteins modulate the kinetics of channel activation and inactivation, the voltage dependence of activation, and recovery from inactivation (Bean, 1989; Patil et al., 1998; Zamponi and Snutch, 1998). Polyglutamine tract expansions in exon 47 (Zhuchenko et al., 1997) shift the voltage dependence of activation to more negative potentials, dramatically increase current density (Piedras-Rentería et al., 1999), and alter activation and inactivation kinetics (Resituito et al., 1999). These latter effects appear to be dependent on coexpression of the beta 4 subunit.

This study focuses on two naturally occurring splice variants of the alpha 1A subunit gene that differ in nucleotide sequences corresponding to the NP exon of the IVS3-IVS4 extracellular linker and C-terminal exons 37 and 44. One variant, alpha 1A-C2, has been identified previously in human cerebellum but has not been expressed and characterized (Zhuchenko et al., 1997) (GenBank number U79663). It lacks the NP exon but contains exons 37a and 44. The other variant, alpha 1A-C16, which has not been identified previously, contains the NP exon and exon 37b but lacks exon 44. Neither alpha 1A-C2 nor alpha 1A-C16 contains exon 47, which is present in the well characterized alpha 1A subunits BI-1 and BI-2 isolated from rabbit brain (Mori et al., 1991; Sather et al., 1993). Because of the central role of the alpha 1A C terminus in defining channel-gating characteristics, we hypothesized that the difference in splicing pattern between the two variants would be reflected by changes in their biophysical properties.

Expression in Xenopus oocytes demonstrated that alpha 1A-C2 and alpha 1A-C16 are similar with respect to current-voltage relationships and the voltage dependency of activation and inactivation. This is different from previously reported results. The presence of the NP exon shifted the voltage dependence of activation and inactivation of a rat brain alpha 1A subunit (Bourinet et al., 1999). In a study conducted with a human alpha 1A subunit, the NP exon only shifted the voltage dependence of inactivation (Hans et al., 1999). Taken together, these data suggest that regions in addition to NP are important for determining the voltage dependence of activation and inactivation. However, other differences, such as the isoform of the Chbeta subunit coexpressed with the alpha 1A subunit, differing expression systems, and the lack of complete inactivation at the end of the conditioning pulse could shift the voltage dependence of inactivation (Hans et al., 1999).

Further characterization reveals differences in the respective rates of activation, inactivation, deactivation, and recovery from inactivation of channels containing the alpha 1A-C2 or alpha 1A-C16 subunits. Complexes containing the alpha 1A-C16 subunit activate more slowly than do those that contain alpha 1A-C2. This may be explained, in part, by the presence of the NP amino acids in the extracellular IVS3-IVS4 linker, which have been shown to decrease the rate of activation of alpha 1A and alpha 1B channel complexes by ~1.5-fold at +10 mV (Hans et al., 1999; Lin et al., 1999). The alpha 1A-C2 complex has an apparent rate of activation that is similar to that of other alpha 1A subunits that lack NP (1.6 ± 0.2 vs 1.2 ± 0.5 msec) (Hans et al., 1999). The activation rate of alpha 1A-C16 is considerably slower than that of other subunits that contain NP (4.8 ± 0.5 vs 2.2 ± 1.1 msec) (Hans et al., 1999), suggesting that other regions of the C terminus also affect activation. Our results indicate that the region encoded by exon 44 appears to be acting in a modular manner to enhance the rate of inactivation of alpha 1A complexes twofold to threefold. It is unclear whether this results from a direct conformational change or whether the presence or absence of this charged sequence affects modulation by intracellular signaling molecules. Further experiments are required to resolve this issue. Interestingly, the regions encoded by exons 43-47 have been shown to bind beta 4 and beta 2a subunits but not beta 1 or beta 3 subunits (Walker et al., 1998). Our results with the beta 1 subunit suggest that changes in inactivation imparted by exon 44 are independent of C-terminal beta  subunit binding. The deactivation rate of the alpha 1A-C16 complex is slightly slower than that of alpha 1A-C2. Because the settling time of the oocyte clamp is ~2 msec, these rates are likely to be faster than we report. Regardless, the alpha 1A-C16 complexes are consistently slower over a wide voltage range (-60 to -100 mV; data not shown). Thus, as is true for the alpha 1C subunit of L-type Ca2+ channels (Soldatov et al., 1997, 1998), C-terminal alternative splicing does affect the biophysical properties of channel complexes composed of alpha 1A subunits.

The slower activation, inactivation, and deactivation of alpha 1A-C16 splice variants relative to alpha 1A-C2 could translate to differences in neurotransmitter release at subtype-specific synapses. Although differences in channel number and density, second messenger effects, and Ca2+ buffering make it difficult to predict what the combined effects of C-terminal splicing on Ca2+ entry will be (Park and Dunlap, 1998; Lin et al., 1999), our results do allow for some generalizations to be made. The slower rate of activation of channels containing the alpha 1A-C16 subunit should lead to a decrease in the initial rate of calcium influx. However, the slower inactivation rate of the alpha 1A-C16 subunit would enhance later calcium entry, providing the channel does not recover from inactivation by passing through the open state (Slesinger and Lansman, 1991). The slower deactivation rate of alpha 1A-C16 channel complexes would increase Ca2+ flux through these channels at a time when the driving force is relatively large. Therefore, it is likely that in response to a single action potential, the initial rate of Ca2+ entry would be slower through complexes containing the alpha 1A-C16 subunit, but these channels would allow for a greater total Ca2+ influx.

The rate of recovery from inactivation at negative potentials plays an important role in determining Ca2+ influx and neurotransmitter release in response to a train of action potentials. The voltage dependence of the rate of recovery of channel complexes containing the alpha 1A-C16 subunit differs from those containing alpha 1A-C2. At less negative potentials, the two splice variants behave similarly. After 500 msec at -60 mV, ~30% of channels composed of either variant are fully recovered. However, at more negative potentials, complexes containing the alpha 1A-C16 subunit recover more slowly. After 500 msec at -80 mV, ~73% of alpha 1A-C2 complexes are recovered, compared with ~62% of alpha 1A-C16 complexes. Thus, Ca2+ entry after a train of action potentials would be less in nerve terminals expressing the alpha 1A-C16 subunit relative to those expressing the alpha 1A-C2 subunit. These differences may be important from the standpoint of Ca2+-mediated synaptic plasticity.

Our results add to a developing picture of neuronal calcium channels that suggests that alpha 1 subunit genes express channels with a wide array of structures and functions. These channels may have evolved to meet the specific needs of highly specialized synapses. Our results, combined with those of several laboratories (Bourinet et al., 1999; Hans et al., 1999), point to the fact that it is no longer sufficient to refer to alpha 1A channels as simply P- and Q-type. Minor splicing events in critical domains of the alpha 1A subunit alter both pharmacological and physiological properties in ways in which we are only beginning to understand. Determination of where specific alpha 1A subunit splice variants are expressed, how they respond to trains of action potentials, and how they interact with various signaling molecules should greatly enhance our understanding of the physiology of the synapse.


    FOOTNOTES

Received Jan. 13, 2000; revised Aug. 1, 2000; accepted Aug. 4, 2000.

This work was supported by National Institutes of Health Grant R29-NS 32094, North Carolina State University Faculty Research and Professional Development Grant 09223-350791, and North Carolina Biotechnology Center Academic Research Initiation Grant 9905 ARG 0044. We would like to thank Drs. Robert Rosenberg and Mark Chapman for advice in the preparation of this manuscript.

Correspondence should be addressed to Dr. William A. Horne, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606. E-mail: Bill_Horne{at}ncsu.edu.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Bean BP (1989) Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340:153-156[Medline].
  • Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP (1999) Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 2:407-415[Web of Science][Medline].
  • Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 64:493-531[Web of Science][Medline].
  • de Leon M, Wang Y, Jones L, Perez-Reyes E, Wei X, Soong TW, Snutch TP, Yue DT (1995) Essential Ca2+-binding motif for Ca2+-sensitive inactivation of L-type Ca2+ channels. Science 270:1502-1506[Abstract/Free Full Text].
  • Dunlap K, Luebke JI, Turner TJ (1995) Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci 18:89-98[Web of Science][Medline].
  • Hans M, Urrutia A, Deal C, Brust PF, Stauderman K, Ellis SB, Harpold MM, Johnson EC, Williams ME (1999) Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha1A-containing high-voltage-activated calcium channels. Biophys J 76:1384-1400[Web of Science][Medline].
  • Jun K, Piedras-Renteria ES, Smith SM, Wheeler DB, Lee SB, Lee TG, Chin H, Adams ME, Scheller RH, Tsien RW, Shin HS (1999) Ablation of P/Q-type Ca2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha1A-subunit. Proc Natl Acad Sci USA 96:15245-15250[Abstract/Free Full Text].
  • Kozak M (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115:887-903[Abstract/Free Full Text].
  • Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA (1999) Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399:155-159[Medline].
  • Lin Z, Lin Y, Schorge S, Pan JQ, Beierlein M, Lipscombe D (1999) Alternative splicing of a short cassette exon in alpha 1B generates functionally distinct N-type calcium channels in central and peripheral neurons. J Neurosci 19:5322-5331[Abstract/Free Full Text].
  • Moreno H, Rudy B, Llinas R (1997) Beta subunits influence the biophysical and pharmacological differences between the P- and Q-type calcium currents expressed in a mammalian cell line. Proc Natl Acad Sci 94:14042-14047[Abstract/Free Full Text].
  • Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, Bosse E, Hoffmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S (1991) Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350:398-402[Medline].
  • Murphy TH, Worley PF, Baraban JM (1991) L-type voltage-sensitive Ca2+ channels mediate synaptic activation of immediate early genes. Neuron 7:625-635[Web of Science][Medline].
  • Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen G-J, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543-552[Web of Science][Medline].
  • Park D, Dunlap K (1998) Dynamic regulation of calcium influx by G-proteins, action potential waveform, and neuronal firing frequency. J Neurosci 18:6757-6766[Abstract/Free Full Text].
  • Patil PG, Brody DL, Yue DT (1998) Preferential closed-state inactivation of neuronal calcium channels. Neuron 20:1027-1038[Web of Science][Medline].
  • Peterson BZ, DeMaria CD, Adelman JP, Yue DT (1999) Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron 22:549-558[Web of Science][Medline].
  • Piedras-Rentería ES, Watase K, Zoghbi HY, Lee CC, Tsien RW (1999) Alteration of expressed alpha1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. Soc Neurosci Abstr 25:431.
  • Qin N, Platano D, Olcese R, Stefani E, Birnbaumer L (1997) Direct interaction of Gbetagamma with a C-terminal Gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci USA 94:8866-8871[Abstract/Free Full Text].
  • Resituito S, Thompson R, Charnet P, Gomez C (1999) Multiple SCA6-associated, alpha1A splice forms may have altered activation/inactivation kinetics. Soc Neurosci Abstr 25:431.
  • Sather WA, Tanabe T, Zhang JF, Mori Y, Adams ME, Tsien RW (1993) Distinctive biophysical and pharmacological properties of class A(BI) calcium channel alpha 1 subunits. Neuron 11:291-303[Web of Science][Medline].
  • Slesinger PA, Lansman JB (1991) Reopening of Ca2+ channels in mouse cerebellar neurons at resting membrane potentials during recovery from inactivation. Neuron 7:755-762[Web of Science][Medline].
  • Soldatov NM, Zühlke RD, Bouron A, Reuter H (1997) Molecular structures involved in L-type calcium channel inactivation. Role of the carboxyl-terminal region encoded by exons 40-42 in alpha 1C in the kinetics and Ca2+ dependence of inactivation. J Biol Chem 272:3560-3566[Abstract/Free Full Text].
  • Soldatov NM, Oz M, O'Brien KA, Abernethy DR, Morad M (1998) Molecular determinants of L-type Ca2+ channel inactivation. Segment exchange analysis of the carboxyl-terminal cytoplasmic motif encoded by exons 40-42 of the human alpha1C subunit gene. J Biol Chem 273:957-963[Abstract/Free Full Text].
  • Sutton KG, Zamponi GW, Bourinet E, Soong TW, Snutch TP (1998) Alternative splicing of the alpha 1a gene generates distinct P- or Q-type sensitivity to omega-Agatoxin IVA. Soc Neurosci Abstr 24:16.
  • Sutton KG, McRory JE, Guthrie H, Murphy TH, Snutch TP (1999) P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A. Nature 401:800-804[Medline].
  • Takahashi T, Momiyama A (1993) Different types of calcium channels mediate central synaptic transmission. Nature 366:156-158[Medline].
  • Tsien RW, Ellinor PT, Horne WA (1991) Molecular diversity of voltage-dependent Ca2+ channels. Trends Pharmacol Sci 12:349-354[Medline].
  • Turner TJ, Adams ME, Dunlap K (1992) Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science 258:310-313[Abstract/Free Full Text].
  • Walker D, Bichet D, Campbell KP, De Waard M (1998) A beta 4 isoform-specific interaction site in the carboxyl-terminal region of the voltage-dependent Ca2+ channel alpha1A subunit. J Biol Chem 273:2361-2367[Abstract/Free Full Text].
  • Westenbroek RE, Ahlijanian MK, Catterall WA (1990) Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons. Nature 347:281-284[Medline].
  • Westenbroek RE, Hoskins L, Catterall WA (1998) Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci 18:6319-6330[Abstract/Free Full Text].
  • Wheeler DB, Randall A, Tsien RW (1994) Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science 264:107-111[Abstract/Free Full Text].
  • Yokoyama CT, Westenbroek RE, Hell JW, Soong TW, Snutch TP, Catterall WA (1995) Biochemical properties and subcellular distribution of the neuronal class E calcium channel alpha 1 subunit. J Neurosci 15:6419-6432[Abstract/Free Full Text].
  • Zamponi GW, Snutch TP (1998) Modulation of voltage-dependent calcium channels by G proteins. Curr Opin Neurobiol 8:351-356[Web of Science][Medline].
  • Zamponi GW, Bourinet E, Nelson D, Nargeot J, Snutch TP (1997) Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha 1 subunit. Nature 385:442-446[Medline].
  • Zhang JF, Randall AD, Ellinor PT, Horne WA, Sather RA, Tanabe T, Schwarz TL, Tsien RW (1993) Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32:1075-1088[Web of Science][Medline].
  • Zhang JF, Ellinor PT, Aldrich RW, Tsien RW (1996) Multiple structural elements in voltage-dependent Ca2+ channels support their inhibition by G proteins. Neuron 17:991-1003[Web of Science][Medline].
  • Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha1A-voltage-dependent calcium channel. Nat Genet 15:62-69[Web of Science][Medline].


Copyright © 2000 Society for Neuroscience  0270-6474/00/20207564-07$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. R. A. K. J. S. Rajapaksha, D. Wang, J. N. Davies, L. Chen, G. W. Zamponi, and T. E. Fisher
Novel Splice Variants of Rat CaV2.1 That Lack Much of the Synaptic Protein Interaction Site Are Expressed in Neuroendocrine Cells
J. Biol. Chem., June 6, 2008; 283(23): 15997 - 16003.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. L. Shang, A. E. Pfahnl, S. Sanyal, Z. Jiao, J. Allen, K. Banach, J. Fahrenbach, D. Weiss, W. R. Taylor, A. M. Zafari, et al.
Human Heart Failure Is Associated With Abnormal C-Terminal Splicing Variants in the Cardiac Sodium Channel
Circ. Res., November 26, 2007; 101(11): 1146 - 1154.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. C. E. Wykes, C. S. Bauer, S. U. Khan, J. L. Weiss, and E. P. Seward
Differential Regulation of Endogenous N- and P/Q-Type Ca2+ Channel Inactivation by Ca2+/Calmodulin Impacts on Their Ability to Support Exocytosis in Chromaffin Cells
J. Neurosci., May 9, 2007; 27(19): 5236 - 5248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Chen and E. S. Piedras-Renteria
Altered frequency-dependent inactivation and steady-state inactivation of polyglutamine-expanded {alpha}1A in SCA6
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1078 - C1086.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. J. Castiglioni, J. Raingo, and D. Lipscombe
Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels
J. Physiol., October 1, 2006; 576(1): 119 - 134.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Kanumilli, E. W. Tringham, C. Elizabeth Payne, J. R. B. Dupere, K. Venkateswarlu, and M. M. Usowicz
Alternative splicing generates a smaller assortment of CaV2.1 transcripts in cerebellar Purkinje cells than in the cerebellum
Physiol Genomics, January 12, 2006; 24(2): 86 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Lin, S. I. McDonough, and D. Lipscombe
Alternative Splicing in the Voltage-Sensing Region of N-Type CaV2.2 Channels Modulates Channel Kinetics
J Neurophysiol, November 1, 2004; 92(5): 2820 - 2830.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. Luvisetto, T. Fellin, M. Spagnolo, B. Hivert, P. F. Brust, M. M. Harpold, K. A. Stauderman, M. E. Williams, and D. Pietrobon
Modal Gating of Human CaV2.1 (P/Q-type) Calcium Channels: I. The Slow and the Fast Gating Modes and their Modulation by {beta} Subunits
J. Gen. Physiol., October 25, 2004; 124(5): 445 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Chaudhuri, S.-Y. Chang, C. D. DeMaria, R. S. Alvania, T. W. Soong, and D. T. Yue
Alternative Splicing as a Molecular Switch for Ca2+/Calmodulin-Dependent Facilitation of P/Q-Type Ca2+ Channels
J. Neurosci., July 14, 2004; 24(28): 6334 - 6342.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Jurkat-Rott and F. Lehmann-Horn
The impact of splice isoforms on voltage-gated calcium channel {alpha}1 subunits
J. Physiol., February 1, 2004; 554(3): 609 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. W. Soong, C. D. DeMaria, R. S. Alvania, L. S. Zweifel, M. C. Liang, S. Mittman, W. S. Agnew, and D. T. Yue
Systematic Identification of Splice Variants in Human P/Q-Type Channel alpha 12.1 Subunits: Implications for Current Density and Ca2+-Dependent Inactivation
J. Neurosci., December 1, 2002; 22(23): 10142 - 10152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Kawasaki, S. C. Collins, and R. W. Ordway
Synaptic Calcium-Channel Function in Drosophila: Analysis and Transformation Rescue of Temperature-Sensitive Paralytic and Lethal Mutations of Cacophony
J. Neurosci., July 15, 2002; 22(14): 5856 - 5864.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Sharon, H. Yamamoto, T. L. McGee, V. Rabe, R. T. Szerencsei, R. J. Winkfein, C. F. M. Prinsen, C. S. Barnes, S. Andreasson, G. A. Fishman, et al.
Mutated Alleles of the Rod and Cone Na-Ca+K-Exchanger Genes in Patients with Retinal Diseases
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1971 - 1979.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. D. Helton and W. A. Horne
Alternative Splicing of the beta 4 Subunit Has alpha 1 Subunit Subtype-Specific Effects on Ca2+ Channel Gating
J. Neurosci., March 1, 2002; 22(5): 1573 - 1582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Tsunemi, H. Saegusa, K. Ishikawa, S. Nagayama, T. Murakoshi, H. Mizusawa, and T. Tanabe
Novel Cav2.1 Splice Variants Isolated from Purkinje Cells Do Not Generate P-type Ca2+ Current
J. Biol. Chem., February 22, 2002; 277(9): 7214 - 7221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. S. Piedras-Renteria, K. Watase, N. Harata, O. Zhuchenko, H. Y. Zoghbi, C. C. Lee, and R. W. Tsien
Increased Expression of alpha 1A Ca2+ Channel Currents Arising from Expanded Trinucleotide Repeats in Spinocerebellar Ataxia Type 6
J. Neurosci., December 1, 2001; 21(23): 9185 - 9193.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krovetz, H. S.
Right arrow Articles by Horne, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krovetz, H. S.
Right arrow Articles by Horne, W. A.

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-